Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Jubilant Life Sciences
Jubilant Life Sciences
Activities:
Manufacturing
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Distribution
Biesterfeld and Jubilant celebrate 25 year partnership on fine chemicals
Biesterfeld Spezialchemie distributes Jubilant Ingrevia’s selected range of products in the field of advanced intermediates to selected customers across Europe
Manufacturing
ON-DEMAND WEBINAR: Delivering the added dimension in Scale-up
Watch Jubilant Biosys' complimentary webinar and live Q&A, hosted in association with Manufacturing Chemist on 7 July, 2020
Delivering the added dimension in Scale-up
7 July 2020 | Webinar
Manufacturing
Jubilant Biosys begins two drug discovery facility expansions in India
The CRO has invested in expansion of the Greater Noida and Bengalaru facilities
Research & Development
Jubilant Biosys strengthens its leadership team with two key appointments
Hires Steven Hutchins as President and Dr Takeshi Yuri as VP of Medicinal Chemistry
Manufacturing
Jubilant Life Sciences to sell licensed and proprietary diabetes and cardiovascular products
Has seen substantial growth in its domestic Indian market with such products
Finance
IFC makes major loan to Jubilant Pharma
To boost generics production
Subscribe now